PFG Advisors Has $3.88 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

PFG Advisors increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 3.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,559 shares of the healthcare conglomerate’s stock after buying an additional 222 shares during the quarter. PFG Advisors’ holdings in UnitedHealth Group were worth $3,882,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in UNH. GSA Capital Partners LLP acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $642,000. Rowland & Co. Investment Counsel ADV bought a new stake in UnitedHealth Group during the fourth quarter worth $169,000. Unigestion Holding SA lifted its stake in UnitedHealth Group by 25.9% during the fourth quarter. Unigestion Holding SA now owns 4,786 shares of the healthcare conglomerate’s stock worth $2,403,000 after purchasing an additional 986 shares during the last quarter. IHT Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 9.9% in the 4th quarter. IHT Wealth Management LLC now owns 3,837 shares of the healthcare conglomerate’s stock valued at $1,927,000 after acquiring an additional 345 shares during the last quarter. Finally, Banco de Sabadell S.A lifted its stake in shares of UnitedHealth Group by 43.1% in the 4th quarter. Banco de Sabadell S.A now owns 10,402 shares of the healthcare conglomerate’s stock valued at $5,235,000 after acquiring an additional 3,132 shares during the last quarter. Institutional investors and hedge funds own 87.25% of the company’s stock.

UnitedHealth Group Stock Up 1.1 %

UnitedHealth Group stock opened at $517.46 on Friday. UnitedHealth Group Incorporated has a 1-year low of $383.12 and a 1-year high of $553.29. The firm has a market capitalization of $484.02 billion, a price-to-earnings ratio of 27.02, a P/E/G ratio of 1.61 and a beta of 0.76. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.60. The firm has a 50 day simple moving average of $530.11 and a 200 day simple moving average of $512.45.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. The firm had revenue of $80.33 billion during the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The business’s revenue for the quarter was up 12.6% on a year-over-year basis. During the same period in the previous year, the business earned $4.70 EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th were given a dividend of $1.65 per share. The ex-dividend date of this dividend was Friday, September 9th. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.28%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.46%.

Analysts Set New Price Targets

UNH has been the subject of a number of research reports. Sanford C. Bernstein cut UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price target for the company. in a research note on Thursday, May 26th. They noted that the move was a valuation call. Raymond James increased their price target on UnitedHealth Group from $620.00 to $635.00 in a research note on Thursday. Oppenheimer increased their price target on UnitedHealth Group from $600.00 to $610.00 and gave the stock an “outperform” rating in a report on Monday, July 18th. Deutsche Bank Aktiengesellschaft raised their target price on UnitedHealth Group from $556.00 to $569.00 and gave the company a “buy” rating in a research note on Thursday, September 8th. Finally, Credit Suisse Group raised their target price on UnitedHealth Group from $575.00 to $579.00 and gave the company an “outperform” rating in a research note on Monday, July 18th. Three equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $586.40.

Insider Activity

In related news, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total value of $252,202.05. Following the completion of the transaction, the chief accounting officer now directly owns 34,786 shares in the company, valued at $18,866,882.82. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total value of $252,202.05. Following the completion of the transaction, the chief accounting officer now directly owns 34,786 shares in the company, valued at $18,866,882.82. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Dirk C. Mcmahon sold 14,715 shares of the company’s stock in a transaction on Thursday, August 18th. The stock was sold at an average price of $543.32, for a total transaction of $7,994,953.80. Following the completion of the transaction, the chief executive officer now owns 50,108 shares of the company’s stock, valued at $27,224,678.56. The disclosure for this sale can be found here. Insiders sold 139,051 shares of company stock worth $74,450,958 in the last three months. Corporate insiders own 0.40% of the company’s stock.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.